Pathology
 |
|
18 january 2019 07:00:21 |
| Better end points needed in primary sclerosing cholangitis trials (Nature Clinical Practice Gastroenterology & Hepatology) |
|
Tweet |
| 68 viewsCategory: Pathology |
 Targeting FLT3 mutations in AML: review of current knowledge and evidence (Leukemia)Author Correction: Pathogenesis and therapeutic interventions for ANCA-associated vasculitis (Nature Clinical Practice Rheumatology) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
